Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04445233 · ClinicalTrials.gov registry record
COVID-19 Household Transmission Study
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 315
- Enrollment target
NCT04445233: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT04445233 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 315 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04445233 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 315 participants
- Enrollment target
Study Summary
This study will test and follow persons quarantined at home after testing positive for SARS-CoV-2 (COV) aged 18 years and older and their household members aged 1 year and older. The purpose of this research study is to understand how often COVID-19 (Coronavirus Disease 2019) spreads in the household when someone who tests positive for the virus self-isolates at home. The purpose of the extension part of the study is to help us understand long-term immunity to COVID-19. We are interested in how our immune system might still protect us from COVID-19 even after antibody levels decrease or are no longer detected. We are also interested in how immunity to COVID-19 is different in kids vs. adults.
Primary Outcome
Secondary household infection rate
Interventions
- DEVICE COVID-19 IgM-IgG Rapid Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2020-04-29 |
| Est. Completion | 2021-09-01 |
What the finished NCT04445233 record still lists
NCT04445233 is an observational study that tracks outcomes without assigning an intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 IgM-IgG Rapid Test is the first listed.
NCT04445233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04445233 about?
NCT04445233 is a clinical study titled "COVID-19 Household Transmission Study". This study will test and follow persons quarantined at home after testing positive for SARS-CoV-2 (COV) aged 18 years and older and their household members aged 1 year and older. The purpose of this research study is to understand how often COVID-19 (Coronavirus Disease 2019) spreads in the househo...
What is the current status of trial NCT04445233?
This trial is currently completed. The enrollment target is 315 participants. The study started on 2020-04-29. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04445233?
The interventions under investigation include: COVID-19 IgM-IgG Rapid Test (DEVICE).
Who is sponsoring clinical trial NCT04445233?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI